Mechanism of client loading from BiP to Grp94 and its disruption by select inhibitors

Tara P Azam1, Luna Han1, Erin E Deans1

  • 1Department of Biochemistry at Brandeis University, Waltham, MA, 02453, USA.

Nature Communications
|April 15, 2025
PubMed

Insights

Heat shock protein 90 (Hsp90) inhibitors affect client protein loading. Some Hsp90 inhibitors disrupt the loading process, offering new strategies for cancer drug design.

Area of Science:

  • Molecular Biology
  • Cancer Biology
  • Structural Biology

Background:

  • Heat shock protein 90 (Hsp90) is a crucial molecular chaperone and a validated cancer drug target.
  • Numerous ATP-competitive Hsp90 inhibitors are in clinical trials for cancer treatment.
  • The precise mechanisms by which Hsp90 inhibitors influence client protein transfer and loading remain incompletely understood.

Purpose of the Study:

  • To investigate how Hsp90 inhibitors affect the client protein delivery, loading, and trapping steps.
  • To elucidate the role of the Hsp70 chaperone BiP in facilitating client loading onto Hsp90 paralog Grp94.
  • To identify structural determinants governing inhibitor effects on Hsp90 client loading.

Main Methods:

  • Comparative analysis of the ER-resident BiP/Grp94 chaperone system (Hsp70/Hsp90 paralogs) in the presence of different Hsp90 inhibitors.
  • Biochemical assays to examine BiP-mediated conformational changes in Grp94.
  • Structural studies to understand inhibitor interactions and their impact on ternary complex formation.

Main Results:

  • Specific Hsp90 inhibitors differentially modulate BiP's ability to induce the client-loading conformation of Grp94.
  • Certain inhibitors block BiP-driven conformational changes, leading to destabilization of BiP/client/Grp94 ternary complexes.
  • A structural basis was identified for selective inhibition of client loading by a subset of Hsp90 inhibitors.

Conclusions:

  • BiP actively drives Grp94 into a client-loading-competent state through a mechanism conserved between ER and cytosolic Hsp70/Hsp90 systems.
  • Understanding these client loading dynamics reveals how specific inhibitors disrupt Hsp90 function.
  • These findings provide a foundation for developing novel, rationally designed Hsp90-targeting cancer therapies.